News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts

Spotlight -

Downstream Processing|

Upstream Processing

Tathagata Ray

Tathagata Ray, is consultant, Global Strategy Deployment, at Merck Life Sciences Pvt, Ltd.

Articles by Tathagata Ray

Close-up of tubes in Brookhaven National Laboratory | Image Credit: © Bill Gallery - © Bill Gallery - stock.adobe.com

Application of the Risk Evaluation Matrix as per USP <665> and <1665> for Evaluation of Leachables Risk from Single-Use Components Used in Biomanufacturing

ByRamesh Raju Mavuleti,K. Vasantakumar Pa,K. Sreedhara Ranganath Pai,Subhasis Banerjee ,Somasundaram Gopalakrishnan,Tathagata Ray

June 6th 2024

Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.

bag of medical serum | Image Credit: © mailsonpignata - © mailsonpignata- Stock.adobe.com

Review of SUT Adoption in Biopharma Manufacturing

ByRamesh Raju Mavuleti,K. Vasantakumar Pa,K. Sreedhara Ranganath Pai,Subhasis Banerjee,Somasundaram Gopalakrishnan,Tathagata Ray

March 15th 2024

The evolution of therapeutic modalities drives the adoption of single-use technologies.

Latest Updated Articles

Review of SUT Adoption in Biopharma Manufacturing
Published: March 15th 2024 | Updated:
Application of the Risk Evaluation Matrix as per USP <665> and <1665> for Evaluation of Leachables Risk from Single-Use Components Used in Biomanufacturing
Published: June 6th 2024 | Updated:

Trending on BioPharm International

Can New Funding Models Support Next-Generation Medicines?

BioPharm Weekly News Roundup—Week of Nov. 3, 2025

© 2025 MJH Life Sciences^®

All rights reserved.